291 related articles for article (PubMed ID: 24402377)
1. p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival.
Re M; Zizzi A; Ferrante L; Stramazzotti D; Goteri G; Gioacchini FM; Olivieri F; Magliulo G; Rubini C
Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1641-51. PubMed ID: 24402377
[TBL] [Abstract][Full Text] [Related]
2. p63 expression in laryngeal squamous cell carcinoma is related to tumor extension, histologic grade, lymph node involvement and clinical stage.
Re M; Magliulo G; Ferrante L; Zizzi A; Santarelli A; Stramazzotti D; Lo Muzio L; Goteri G; Rubini C
J Biol Regul Homeost Agents; 2013; 27(1):121-9. PubMed ID: 23489692
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of HAX-1 expression in laryngeal carcinoma.
You Y; Yao H; You B; Li X; Ni H; Shi S; Shan Y; Cao X
Auris Nasus Larynx; 2015 Aug; 42(4):299-304. PubMed ID: 25554539
[TBL] [Abstract][Full Text] [Related]
4. The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma.
Gioacchini FM; Alicandri-Ciufelli M; Magliulo G; Rubini C; Presutti L; Re M
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1569-76. PubMed ID: 24890978
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Beclin-1 expression in laryngeal squamous cell carcinoma.
Huang L; Wang S; Li SS; Yang XM
Pathol Oncol Res; 2013 Oct; 19(4):771-7. PubMed ID: 23686476
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Kif2a and Ki67 expression predicts poor survival in laryngeal squamous cell carcinoma.
Zhang Q; Zhang W; Zhang J; Xu H; You Y
Auris Nasus Larynx; 2016 Aug; 43(4):433-9. PubMed ID: 26602436
[TBL] [Abstract][Full Text] [Related]
7. Notch1 overexpression associates with poor prognosis in human laryngeal squamous cell carcinoma.
Li D; Dong P; Wu C; Cao P; Zhou L
Ann Otol Rhinol Laryngol; 2014 Oct; 123(10):705-10. PubMed ID: 24789803
[TBL] [Abstract][Full Text] [Related]
8. Standardised Ki-67 proliferation index assessment in early-stage laryngeal squamous cell carcinoma in relation to local control and survival after primary radiotherapy.
Kop E; de Bock GH; Noordhuis MG; Slagter-Menkema L; van der Laan BFAM; Langendijk JA; Schuuring E; van der Vegt B
Clin Otolaryngol; 2020 Jan; 45(1):12-20. PubMed ID: 31561282
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of integrin-linked kinase in laryngeal squamous cell carcinoma.
Wu PA; Li SS; Tang QL; Liu BB; Yang XM
Auris Nasus Larynx; 2017 Aug; 44(4):458-463. PubMed ID: 28188026
[TBL] [Abstract][Full Text] [Related]
10. Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma.
Yang F; Ma H; Feng L; Lian M; Wang R; Fan E; Fang J
Int J Clin Exp Pathol; 2015; 8(11):13886-99. PubMed ID: 26823701
[TBL] [Abstract][Full Text] [Related]
11. [Aberrant expression of CyclinE and p27 in laryngeal squamous cell carcinoma and the clinical significance].
Chai D; Bao Z; Hu J; Ma L; Feng Z; Tao Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(3):165-9, 174. PubMed ID: 24826452
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic score model incorporating CDGSH iron sulfur domain2 (CISD2) predicts risk of disease progression in laryngeal squamous cell carcinoma.
Yang L; Hong S; Wang Y; He Z; Liang S; Chen H; He S; Wu S; Song L; Chen Y
Oncotarget; 2016 Apr; 7(16):22720-32. PubMed ID: 27007153
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of γ-H2AX in laryngeal squamous cell carcinoma after surgery.
Zhang J; Cheng L; Zhou L
Chin Med J (Engl); 2014; 127(14):2664-7. PubMed ID: 25043086
[TBL] [Abstract][Full Text] [Related]
14. DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.
Shen Z; Ren W; Bai Y; Chen Z; Li J; Li B; Jin T; Cao P; Shao Y
Oncotarget; 2016 Nov; 7(48):79596-79604. PubMed ID: 27793000
[TBL] [Abstract][Full Text] [Related]
15. [Survivin expression in laryngeal squamous cell carcinoma and its relationship with clinical factors].
Chen YF; Chen FJ; Fang Y; Yang AK; Zhang Q; Wu GH
Ai Zheng; 2004 Nov; 23(11 Suppl):1493-7. PubMed ID: 15566665
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of 659 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations.
Tang D; Tao L; Zhou L; Zhang M; Wu H; Li X; Chen X; Li C; Xie M; Cheng L
Acta Otolaryngol; 2018 Nov; 138(11):1043-1050. PubMed ID: 30776268
[TBL] [Abstract][Full Text] [Related]
17. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
[TBL] [Abstract][Full Text] [Related]
18. [The clinical significance of the expression of p63 gene in laryngeal squamous cell carcinoma].
Jia H; Wang J; Shan Y; Hou J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Feb; 20(3):119-21. PubMed ID: 16646404
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis of laryngeal carcinoma without laryngectomy, radiotherapy, or chemotherapy.
Yu Q; Zhang X; Ji C; Yang H; Gao M; Hong S; Hu G
Eur Arch Otorhinolaryngol; 2012 Sep; 269(9):2103-9. PubMed ID: 22186766
[TBL] [Abstract][Full Text] [Related]
20. The EGFR-mTOR pathway and laryngeal cancer angiogenesis.
Lionello M; Lovato A; Staffieri A; Blandamura S; Turato C; Giacomelli L; Staffieri C; Marioni G
Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):757-64. PubMed ID: 24065188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
